1. Home
  2. CYCN vs OBLG Comparison

CYCN vs OBLG Comparison

Compare CYCN & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCN
  • OBLG
  • Stock Information
  • Founded
  • CYCN 2018
  • OBLG 2000
  • Country
  • CYCN United States
  • OBLG United States
  • Employees
  • CYCN N/A
  • OBLG N/A
  • Industry
  • CYCN Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • CYCN Health Care
  • OBLG Technology
  • Exchange
  • CYCN Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • CYCN 6.5M
  • OBLG 5.5M
  • IPO Year
  • CYCN N/A
  • OBLG N/A
  • Fundamental
  • Price
  • CYCN $3.30
  • OBLG $4.50
  • Analyst Decision
  • CYCN
  • OBLG
  • Analyst Count
  • CYCN 0
  • OBLG 0
  • Target Price
  • CYCN N/A
  • OBLG N/A
  • AVG Volume (30 Days)
  • CYCN 32.1K
  • OBLG 100.9K
  • Earning Date
  • CYCN 08-06-2025
  • OBLG 08-06-2025
  • Dividend Yield
  • CYCN N/A
  • OBLG N/A
  • EPS Growth
  • CYCN N/A
  • OBLG N/A
  • EPS
  • CYCN N/A
  • OBLG N/A
  • Revenue
  • CYCN $2,081,000.00
  • OBLG $2,374,000.00
  • Revenue This Year
  • CYCN N/A
  • OBLG N/A
  • Revenue Next Year
  • CYCN N/A
  • OBLG N/A
  • P/E Ratio
  • CYCN N/A
  • OBLG N/A
  • Revenue Growth
  • CYCN N/A
  • OBLG N/A
  • 52 Week Low
  • CYCN $1.27
  • OBLG $1.91
  • 52 Week High
  • CYCN $9.47
  • OBLG $7.80
  • Technical
  • Relative Strength Index (RSI)
  • CYCN 53.30
  • OBLG 56.66
  • Support Level
  • CYCN $2.95
  • OBLG $4.40
  • Resistance Level
  • CYCN $3.74
  • OBLG $4.97
  • Average True Range (ATR)
  • CYCN 0.34
  • OBLG 0.49
  • MACD
  • CYCN 0.05
  • OBLG 0.07
  • Stochastic Oscillator
  • CYCN 57.28
  • OBLG 70.91

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: